Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance

Chuen Ming Shih, Kwunmin Chen, Yu-Chieh Wang, Pei Jung Lee, Yi Ching Wang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Clinical and experimental studies suggest that alteration of the expression level of the p53 gene and other damage responsive genes may be associated with chemoresistance in cancer patients. Methods: The present study evaluated the differences of the basal levels of lymphocytic p53 and p21waf1 mRNA expression collected before receiving cisplatin-based chemotherapy between 48 chemo-ineffective lung cancer patients and 39 chemo-effective lung cancer patients using an optimized semi-quantitative multiplex reverse transcriptase-polymerase chain reaction (RT-PCR). Results: The data indicated that the mean mRNA level of p53 gene in chemo-ineffective patients (0.66) was 26.9% higher than that of the chemo-effective patients (0.52) with statistical significance (P = 0.03), and a significantly higher level of p21waf1 mRNA expression in the chemo-ineffective patients (P = 0.03) was also observed. In addition, by the multiplex long quantitative PCR analysis, we demonstrated that chemo-ineffective and chemo-effective patients have similar amounts of UV damage on their p53 gene of lymphocyte DNA through equal UV treatment. Conclusion: Our results suggest that elevated levels of p53/p21waf1 mRNA in blood lymphocytes collected before chemotherapy may predict the chemoresponses of lung cancer patients.

Original languageEnglish
Pages (from-to)366-370
Number of pages5
JournalCancer Detection and Prevention
Volume31
Issue number5
DOIs
StatePublished - 4 Dec 2007

Fingerprint

Lung Neoplasms
Lymphocytes
Messenger RNA
p53 Genes
Drug Therapy
Multiplex Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
Cisplatin
Polymerase Chain Reaction
DNA
Genes
Neoplasms

Keywords

  • Chemoresistance
  • Lung cancer
  • Lymphocyte
  • p21waf1 gene
  • p53 gene

Cite this

Shih, Chuen Ming ; Chen, Kwunmin ; Wang, Yu-Chieh ; Lee, Pei Jung ; Wang, Yi Ching. / Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance. In: Cancer Detection and Prevention. 2007 ; Vol. 31, No. 5. pp. 366-370.
@article{ef4cb6d067f9472c87097ff65851cd73,
title = "Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance",
abstract = "Background: Clinical and experimental studies suggest that alteration of the expression level of the p53 gene and other damage responsive genes may be associated with chemoresistance in cancer patients. Methods: The present study evaluated the differences of the basal levels of lymphocytic p53 and p21waf1 mRNA expression collected before receiving cisplatin-based chemotherapy between 48 chemo-ineffective lung cancer patients and 39 chemo-effective lung cancer patients using an optimized semi-quantitative multiplex reverse transcriptase-polymerase chain reaction (RT-PCR). Results: The data indicated that the mean mRNA level of p53 gene in chemo-ineffective patients (0.66) was 26.9{\%} higher than that of the chemo-effective patients (0.52) with statistical significance (P = 0.03), and a significantly higher level of p21waf1 mRNA expression in the chemo-ineffective patients (P = 0.03) was also observed. In addition, by the multiplex long quantitative PCR analysis, we demonstrated that chemo-ineffective and chemo-effective patients have similar amounts of UV damage on their p53 gene of lymphocyte DNA through equal UV treatment. Conclusion: Our results suggest that elevated levels of p53/p21waf1 mRNA in blood lymphocytes collected before chemotherapy may predict the chemoresponses of lung cancer patients.",
keywords = "Chemoresistance, Lung cancer, Lymphocyte, p21waf1 gene, p53 gene",
author = "Shih, {Chuen Ming} and Kwunmin Chen and Yu-Chieh Wang and Lee, {Pei Jung} and Wang, {Yi Ching}",
year = "2007",
month = "12",
day = "4",
doi = "10.1016/j.cdp.2007.10.003",
language = "English",
volume = "31",
pages = "366--370",
journal = "Cancer Detection and Prevention",
issn = "0361-090X",
publisher = "Elsevier BV",
number = "5",

}

Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance. / Shih, Chuen Ming; Chen, Kwunmin; Wang, Yu-Chieh; Lee, Pei Jung; Wang, Yi Ching.

In: Cancer Detection and Prevention, Vol. 31, No. 5, 04.12.2007, p. 366-370.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance

AU - Shih, Chuen Ming

AU - Chen, Kwunmin

AU - Wang, Yu-Chieh

AU - Lee, Pei Jung

AU - Wang, Yi Ching

PY - 2007/12/4

Y1 - 2007/12/4

N2 - Background: Clinical and experimental studies suggest that alteration of the expression level of the p53 gene and other damage responsive genes may be associated with chemoresistance in cancer patients. Methods: The present study evaluated the differences of the basal levels of lymphocytic p53 and p21waf1 mRNA expression collected before receiving cisplatin-based chemotherapy between 48 chemo-ineffective lung cancer patients and 39 chemo-effective lung cancer patients using an optimized semi-quantitative multiplex reverse transcriptase-polymerase chain reaction (RT-PCR). Results: The data indicated that the mean mRNA level of p53 gene in chemo-ineffective patients (0.66) was 26.9% higher than that of the chemo-effective patients (0.52) with statistical significance (P = 0.03), and a significantly higher level of p21waf1 mRNA expression in the chemo-ineffective patients (P = 0.03) was also observed. In addition, by the multiplex long quantitative PCR analysis, we demonstrated that chemo-ineffective and chemo-effective patients have similar amounts of UV damage on their p53 gene of lymphocyte DNA through equal UV treatment. Conclusion: Our results suggest that elevated levels of p53/p21waf1 mRNA in blood lymphocytes collected before chemotherapy may predict the chemoresponses of lung cancer patients.

AB - Background: Clinical and experimental studies suggest that alteration of the expression level of the p53 gene and other damage responsive genes may be associated with chemoresistance in cancer patients. Methods: The present study evaluated the differences of the basal levels of lymphocytic p53 and p21waf1 mRNA expression collected before receiving cisplatin-based chemotherapy between 48 chemo-ineffective lung cancer patients and 39 chemo-effective lung cancer patients using an optimized semi-quantitative multiplex reverse transcriptase-polymerase chain reaction (RT-PCR). Results: The data indicated that the mean mRNA level of p53 gene in chemo-ineffective patients (0.66) was 26.9% higher than that of the chemo-effective patients (0.52) with statistical significance (P = 0.03), and a significantly higher level of p21waf1 mRNA expression in the chemo-ineffective patients (P = 0.03) was also observed. In addition, by the multiplex long quantitative PCR analysis, we demonstrated that chemo-ineffective and chemo-effective patients have similar amounts of UV damage on their p53 gene of lymphocyte DNA through equal UV treatment. Conclusion: Our results suggest that elevated levels of p53/p21waf1 mRNA in blood lymphocytes collected before chemotherapy may predict the chemoresponses of lung cancer patients.

KW - Chemoresistance

KW - Lung cancer

KW - Lymphocyte

KW - p21waf1 gene

KW - p53 gene

UR - http://www.scopus.com/inward/record.url?scp=36549020728&partnerID=8YFLogxK

U2 - 10.1016/j.cdp.2007.10.003

DO - 10.1016/j.cdp.2007.10.003

M3 - Article

C2 - 18035504

AN - SCOPUS:36549020728

VL - 31

SP - 366

EP - 370

JO - Cancer Detection and Prevention

JF - Cancer Detection and Prevention

SN - 0361-090X

IS - 5

ER -